By Lebone Rodah Mosima
Durban-born researcher Dr Sahil Tulsi has provided important new insights into how genetic differences among South Africans may influence responses to TB treatment.
Tulsi, who earned his Doctor of Philosophy in Virology from the University of KwaZulu-Natal, examined how genetic variation affects the way patients process anti-TB medication in his study, Influence of Drug Transporter Gene Polymorphisms on Pharmacogenetic and Treatment Outcomes in African Mycobacterium tuberculosis Cohorts.
His research highlights a critical gap in global health science — the underrepresentation of African genetic data in studies that inform treatment approaches.
For the full story, click the link below.
INSIDE POLITICS
